Abstract:Roux-en Y gastric bypass (RYGB) surgery is among the most effective treatments for obesity, with the majority of weight lost as fat.Recent studies in humans and rats have demonstrated that RYGB alters gut microbial composition.Given the recently recognized link among diet, the gut microbiota, and host adiposity, we hypothesized that alterations in the gut microbiota after RYGB may contribute to the effects of this operation on the regulation of energy balance.16S rRNA pyrosequencing of bacterial DNA isolated from fecal samples revealed dramatic changes in gut microbial composition in diet-induced obese (DIO) mice that had undergone RYGB and were maintained on a 60% fat (kcal) diet, as compared to SHAM-operated (SO) animals maintained on the same diet.These effects occurred within one week after surgery and are characterized by multiple changes in microbial ecology, including a substantially increased prevalence of Proteobacteria.Weight loss induced by caloric restriction (weightmatched SO; WMS) did not show the same alterations in fecal microbiota as RYGB but were more similar to ad libitum fed SO animals, indicating that the observed changes in microbial ecology are specific to the surgical manipulation itself.Consistent with this conclusion, RYGB caused similar changes in the gut microbiota in non-obese animals maintained on a normal chow diet (14% fat; kcal).To assess the contribution of the RYGB-modified microbiota to the therapeutic effects of RYGB, we colonized germ free (GF) mice with cecal contents from either RYGB-treated or SO donor mice.GF recipients of SO donor cecal contents (SHAM-R) had 35% greater visceral adipose tissue than uninnoculated GF mice.In contrast, GF recipients of RYGB-treated donor cecal contents (RYGB-R) had 2% less visceral adipose tissue than the uninnoculated GF controls.The RYGB-R reconstituted mice had 27% less visceral adipose tissue than the SHAM-R reconstituted mice.RYGB-R mice also had 22% less visceral adipose tissue than GF mice colonized with cecal contents from WMS donors, suggesting that changes in gut microbial regulation of host adiposity after RYGB are independent of surgery-induced changes in body weight.These observations suggest that the alteration in microbial composition after RYGB contributes to the profound changes in energy balance and diminished adiposity induced by this operation.Elucidating the mechanisms by which altered gut microbiota exert these effects on host metabolic pathways will increase our understanding of the role of the gut on metabolic function more generally, revealing novel regulatory mechanisms that could be exploited to develop new, more effective nonsurgical therapies for obesity and related metabolic disorders.

GLP-1 Receptor Signaling is Not Required for Reduced Body Weight after RYGB in Rodents.

Combined loss of GLP-1R and Y2R does not alter progression of high-fat diet-induced obesity or response to RYGB surgery in mice

Unlike calorie restriction, Roux-en-Y gastric bypass surgery does not increase hypothalamic AgRP and NPY in mice on a high-fat diet

Reprogramming of Defended Body Weight after Roux-En-Y Gastric Bypass Surgery in Diet-Induced Obese Mice

Farnesoid X receptor contributes to body weight-independent improvements in glycemic control after Roux-en-Y gastric bypass surgery in diet-induced obese mice

Reversible Hyperphagia And Obesity In Rats With Gastric Bypass By Central Mc3/4r Blockade

518 Patch Clamp Recordings Reveal Paracellular (tight Junction) Ion Channels

Lower ghrelin levels does not impact the metabolic benefit induced by Roux-en-Y gastric bypass

Roux-en-Y Gastric Bypass Surgery is Effective in Fibroblast Growth Factor-21 Deficient Mice

Gastric Inhibitory Polypeptide (GIP) is Selectively Decreased in the Roux-Limb of Dietary Obese Mice after RYGB Surgery

Vagal innervation of intestine contributes to weight loss After Roux-en-Y gastric bypass surgery in rats.

Contribution of Endogenous Glucagon-Like Peptide-1 to Changes in Glucose Metabolism and Islet Function in People with Type 2 Diabetes Four Weeks after Roux-en-Y Gastric Bypass (RYGB).

RYGB Is More Effective than VSG at Protecting Mice from Prolonged High-Fat Diet Exposure: An Occasion to Roll Up Our Sleeves?

Suppression of enteroendocrine cell glucagon-like peptide (GLP)-1 release by fat-induced small intestinal ketogenesis: a mechanism targeted by Roux-en-Y gastric bypass surgery but not by preoperative very-low-calorie diet

Dual effect of RYGB on the entero-insular axis: How GLP-1 is enhanced by surgical duodenal exclusion

Increased Energy Expenditure and Energy Loss Through Feces Contribute to the Long-Term Outcome of Roux-en-Y Gastric Bypass in a Diet-Induced Obese Mouse Model

Body Composition, Food Intake, and Energy Expenditure in a Murine Model of Roux-en-Y Gastric Bypass Surgery.

Differential effects of RYGB surgery and best medical treatment for obesity-diabetes on intestinal and islet adaptations in obese-diabetic ZDSD rats

Changes of Serum Lipopolysaccharide, Inflammatory Factors, and Cecal Microbiota in Obese Rats with Type 2 Diabetes Induced by Roux-en-Y Gastric Bypass

Eating in Mice with Gastric Bypass Surgery Causes Exaggerated Activation of Brainstem Anorexia Circuit